Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Predictive Plasma Biomarkers in Pancreatic Ductal Adenocarcinoma (PDAC Plasma Biomarker Study)

NCT02050997 is registered in ClinicalTrials.gov with Cancer Trials Ireland as lead sponsor.

NCT NCT02050997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02050997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Predictive Plasma Biomarkers in Pancreatic Ductal Adenocarcinoma (PDAC Plasma Biomarker Study)
Lead sponsor
Cancer Trials Ireland
Phase
Observational
Overall status
Terminated
Start date
May 26, 2014
Completion date
December 31, 2021
Enrollment
169 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic ductal adenocarcinoma